Sangamo Therapeutics ($SGMO)

Description

Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom management.

Related

• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Vertex Pharmaceuticals (San Diego)Discovers, develops, and produces medicines for serious diseases, while providing medical information, patient support, and clinical trial…
• Neumora TherapeuticsDevelops treatments for brain diseases, advancing CNS-targeted medicines and precision approaches to understand disease biology and…
• Scripps ResearchConducts nonprofit biomedical research and drug discovery, translating scientific findings into improved disease diagnosis, prevention,…
• Crinetics Pharmaceuticals, Inc.Crinetics Pharmaceuticals develops endocrine-focused medicines, advancing programs and partnerships intended to improve treatment options…
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• Variant BioDevelops precision medicines using genomic data from people with exceptional health traits to identify genetically supported targets for…
• Exact Sciences ($EXAS)Builds cancer tests that assess hereditary risk, screen for cancer, and analyze tumor genomics to support patients and clinicians in…
• Xaira TherapeuticsBuilds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation…
• Esperion Therapeutics ($ESPR)Develops and commercializes medicines for cardiovascular disease, including cholesterol management, cardiovascular risk reduction, and…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…